Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
Search by expertise, name or affiliation
Impact of the immunomodulatory effect of the combination HDACis/IMiDs in myelome multiple (MM).
Janji, Bassam
(PI)
Berchem, Guy
(PI)
Aouali, Nassera
(CoPI)
Giuliani, Massimo
(PI)
Tumor Immunotherapy and Microenvironment
Luxembourg Institute of Health
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Western Blot
100%
Multiple Myeloma
100%
Combination Drug
100%
Neoplasm
100%
Cytokine
100%
Tumor Microenvironment
100%
Histone Deacetylase Inhibitor
100%
Glucocorticoid
100%
Immunology and Microbiology
Natural Killer Cell
100%
Immune System
80%
Exocytosis
40%
Cells of the Immune System
20%
Cell Line
20%
Cytokine Production
20%
Tumor Cell
20%
Cytotoxicity
20%
Surface Property
20%
Cell Granule
20%
Target Cell
20%
Glucocorticoid
20%
Multiple Myeloma
20%
Cell Activation
20%
Immunomodulatory Drug
20%
Western Blot
20%
Signal Transduction
20%